Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Pharmacoepidemiology and Drug Safety|December 28, 2020
Confirming diagnoses of acute pancreatitis with commonly available electronic dataGregory A Nichols, Anouk Déruaz-Luyet, Hristo Iliev, et al.Diabetes Research and Clinical Practice|August 3, 2015
Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes mellitus in the United KingdomKaan Tunceli, Kristy Iglay, Changgeng Zhao, et al.Journal of Diabetes and Its Complications|January 21, 2018
The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetesGregory A Nichols, Anouk Déruaz-Luyet, Sibylle J Hauske, et al.Drugs & Aging|April 1, 2015
Sulfonylurea use and risk of hip fractures among elderly men and women with type 2 diabetesSwapnil N Rajpathak, Chunmay Fu, Kimberly G Brodovicz, et al.Journal of Diabetes Investigation|January 23, 2019
Preferential prescribing of linagliptin in type 2 diabetes patients in an expanded post-marketing surveillance study in JapanSoulmaz Fazeli Farsani, Atsushi Taniguchi, Rie Ikeda, et al.Pharmacoepidemiology and Drug Safety|May 20, 2016
Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD)Jin-Liern Hong, Ann Marie McNeill, Jinghua He, et al.Endocrinology, Diabetes & Metabolism|March 1, 2019
Preferential prescribing and utilization trends of diabetes medications among patients with renal impairment: Emerging role of linagliptin and other dipeptidyl peptidase 4 inhibitorsElisabetta Patorno, Chandrasekar Gopalakrishnan, Dorothee B Bartels, et al.Journal of the American Society of Nephrology : JASN|June 4, 2020
Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart FailureGregory A Nichols, Anastasia Ustyugova, Anouk Déruaz-Luyet, et al.Diabetes, Obesity & Metabolism|February 25, 2020
Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States from 2010 to 2014Anouk Déruaz-Luyet, Christina Raabe, Elizabeth M Garry, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 7, 2015
Characterization of Sitagliptin Use in Patients with Type 2 Diabetes and Chronic Kidney Disease by Cross-Sectional Analysis of a Medical Insurance Claims DatabaseKimberly G Brodovicz, Yong Chen, Zhiwen Liu, et al.Pageof 4